All Type of News
Seoul National University Hospital ranked the top for 15 consecutive years in the top brand power list
According to the analysis result of ‘Korea Brand Power Index (hereinafter reffering to K-BPI)’ conducted by the Korea Management Association Consulting (KMAC, CEO Jong-lip Kim), Seoul National University Hospital has ...
Listed pharmaceutical companies recorded the most cash dividends with KRW 160 billion in average
Listed pharmaceutical companies will execute the largest cash dividends of all time.
According to the YakupDotCom’s analysis result of 43 pharmaceutical companies deciding cash dividends, the scale of their cash divi...
The pharmaceutical industry is experiencing diastrophism with divisions and mergers
The pharmaceutical industry is experiencing diastrophism.
Pharmaceutical companies have actively expanded to other businesses as diversification, and some of them have secured professionalism through divestitures.
A...
There were 452 patent extension applications for pharmaceutical products, causing KRW 3 trillion profits
It is observed that the market profits of original pharmaceutical products – that is, generated through patent extension of newly registered pharmaceutical products – have exceeded approximately KRW 3 trillion. The ca...
Domestic and multinational pharmaceutical companies have begun countdowns in the DDP-4 type anti-diabetes treatment market
DDP-4 (dipeptidyl peptidase-4) inhibitors, leading the diabetes treatment market, are expected to be shaken. Launched of DPP-4 inhibitor-type new drugs, such as adjusted lineup extensions, will be made.
Although the ...
While Champix is in the process of the insurance benefit, other OTC supplements are looking for chances
While the government has confirmed to apply the National Health Insurance in antismoking treatments in the second half of the year, its related treatments have actively been planning to register the program.
Accordin...
The co-developed new anticancer drug by the government and Hanmi will be exported to a U.S. pharmaceutical company
The Ministry of Health and Welfare unveiled on the 5th that it exported the technology of a new anticancer substance (Poziotinib), which has co-developed by a private company and the government, to a anticancer develo...
“Xeljanx is expected to overcome the limitation of rheumarthritis treatments”
As the first oral treatment for rheumarthritis, Xeljanz, has been launched, it is noticed that a new era has been opened in the rheumarthritis treatment market.
Pfizer Korea announced the launch of the oral rheumarth...
Abbott Korea, exclusively owning Ganaton, will make direct marketing in the Korean market
Abbott Korea has acquired the selling rights of the indigestion treatment, Ganaton, and will conduct direct marketing in the Korean market.
According to the company on the 5th, as the license agreement of Ganaton wit...
The annual prescription expenses of hypertension and degenerative arthritis are KRW 160 thousand and KRW 40 thousand
It is analyzed that patient-shared prescription expenses of the first and second chronic diseases, hypertension and degenerative arthritis, are respective KRW 158 thousand and KRW 41 thousand annually. In particular, ...
